Related Experiment Video
Updated: Aug 18, 2026

Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
Can apoptosis in benign proliferative lesions predict risk of cancer development?
1Department of Toxicology, Abbott Laboratories, Abbott Park, Illinois, USA.
Abstract:
The presence of benign proliferative lesions is a risk factor for the development of cancer. However, only a subset of individuals presenting with benign lesions goes on to develop cancer. It is a major challenge of cancer research to identify those individuals at increased risk for this neoplastic progression. It has been suggested that individuals with inherent genomic instability may have a predisposition for cancer development. The hypothesis is presented that this genetic instability could be quantified through the analysis of apoptosis in biopsies of benign lesions. It is further conjectured that genetic damage-dependent apoptosis might serve as a prognostic indicator to identify individuals at increased risk for cancer.
Related Concept Videos
Abnormal Proliferation
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway
Abnormal Proliferation
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

